AZTA

Azenta, Inc.

Healthcare · $1.6B market cap

Verdict

We can't put a fair value on AZTA right now. It lost money in at least 2 of its last 3 years, so one year of cash flow isn't a reliable base to value it on.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-1.8% a year✗
Equity per share growth8.9% a year✗
Sales growth0.4% a year✗
Free cash flow growth1.8% a year✗
Return on invested capital-0.3%✗

Follow AZTA

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Oct 22, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

Questions about AZTA

Are insiders buying AZTA?

Since Oct 22, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar).

How can I check AZTA's value myself?

Use the free Sticker Price calculator, already filled with AZTA's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →

Similar stocks · Medical - Instruments & Supplies

About Azenta, Inc.

Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 23, 2026. How the Payback Price works